Human relevance of pre-clinical studies in Mesenchymal stem cell therapy: systematic review and meta

来源 :第二届中国女医师大会 | 被引量 : 0次 | 上传用户:liubifeng1392
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND/AIMS Mesenchymal stem cell (MSC) therapy is a treatment strategy for the acute and chronic kidney diseases induced renal failure. Nowadays, the researches are mostly focused on the experimental methods. Meta-analysis of recently small animal experiments of acute and chronic kidney diseases could provide significant clues to design large animal experiments and human clinical trials. METHODS A total of 24 studies published were analyzed, which were indexed from PubMed and Embase databases (up to Feb., 2012). All of data were analyzed using RevMan 5.1, STATA 11.0 and SPSS 17.0 software. Pooled analysis and multivariable meta-regression were calculated by random effects models. Heterogeneity and publication bias across the studies were also explored. RESULTS Pooled analysis showed a serum creatinine (Scr) reduction followed MSC therapy (95% confidence interval 34.49μmol/L-51.55μmol/L, P<0.001, vs control). By exploratory multivariable meta-regression, significant influence factor of Scr reduction was route of cell delivery (p=0.01). Arterial delivery of MSCs caused more reduction of Scr and preserved impaired renal function better, when compared with the intra-renal delivery and intravenous injection. The subgroup analysis showed trend towards more reduction with renal ischemia-reperfusion injury (IRI) model, compared with cisplatin induced toxic, glycerol induced toxic-ischemic and 5/6 nephrectomy induced chronic renal failure(CRF) animal models. Unexpectedly, high cell number of MSCs (≥2×106, range from 7.5x104 to 1.5x106 ) did not decrease the levels of Scr more than low cell number (<2×106 dose, range from 2×106 to 9×106). CONCLUSION The present meta-analysis confirmed that MSC therapy could improve the impaired renal function observed through Scr detection. And the date suggested that MSC therapy with arterial delivery route or with renal IRI experimental model achieved better effect, however, increase of the MSC dose could not elevate the treatment effect. This meta-analysis may provide much important clues for further animal experiments even human clinical trials in MSC study.
其他文献
目的:研究MTHFR(methylenetetrahydrofolate reductase)基因的C677T和A1298C两个SNPs的分布对儿童急性淋巴细胞白血病(ALL)患儿接受大剂量甲氨蝶呤(HD-MTX)化疗后毒副反应发生情况的影响。方法:收集42例ALL患儿外周血,提取基因组DNA,用PCR片段直接测序的方法检测MTHFR基因型;观察HD—MTX对患儿产生的毒副反应并评级,毒性反应分度
PURPOSE. To study the efficacy and safety of factor VII (fVII)-verteporfin for targeted photodynamic therapy (TPT) compared with nontargeted photodynamic therapy (PDT) in a rat model of choroidal neov
会议
目的:探讨中国人弥漫性大B细胞淋巴瘤(Diffuse large B-cell lymphoma,DLBCL)的临床病理学、免疫表型特点及其与临床预后之间的关系;分析Bcl-2蛋白表达以及Hans、Chan及Muris分类模型对DLBCL预后的提示意义,寻找能够提示预后和指导临床治疗的最适合国人DLBCL的分类模型.材料和方法:本课题选用237例中国内地DLBCL病例,使用石蜡切片免疫组化染色,检
Toll样受体(TLR)是一类典型的模式识别受体(PRR),不仅在天然免疫中起重要作用,同时也被视为天然免疫与获得性免疫的连接点,并影响获得性免疫。对TLRs家族的研究,探讨Toll样受体在尖锐湿疣发病中的作用,可以为尖锐湿疣的免疫学发病机制提供可参考的理论依据,和对尖锐湿疣的治疗新途径以及靶点提供思路。
目的:检测糖尿病肾病(DN)肾小球中脂肪型脂肪酸结合蛋白(FABP4)和内质网应激(ERS)相关蛋白的表达变化,同时检测抗凋亡蛋白Bcl-2的表达,探讨FABP4在ERS介导的细胞凋亡中的作用。方法:采用免疫组化方法检测45例DN和10例微小病变型肾病(MCGN)肾活检组织中FABP4、GRP78、Caspase-12和Bcl-2的表达,应用Image-Pro-Plus5.0软件进行肾小球上述指标
目的:描述北京在校大学生敏感皮肤状态的分布,探讨其发生的影响因素。方法:对北京在校大学生抽样进行敏感皮肤流行病学研究。结果:1.北京地区在校大学生敏感皮肤发生率为39.46%.男性敏感皮肤发生率为30.04%,女性为48.03%,女性高于男性(P<0.01)。2.影响敏感皮肤发生的内在因素主要有性别、解剖部位、个人及家族敏感性疾病病史、内分泌、精神紧张、目光敏感、混合性皮肤、面部皮肤薄和面部毛细血
目的:研究γ-干扰素(IFN-γ)对小鼠巨噬细胞株RAw264.7吞噬、杀伤阿萨希毛孢子菌(Trichospororasahii,T.asahii)的作用,探讨IFN-γ临床治疗T.asahii感染的可能性。方法:不同浓度(10、100、1000U/ml)的γ-干扰素与RAW264.7细胞共孵育18h后,分别与T.asahii临床株共培养45min、4h(不加γ-干扰素组为对照组)。45min后在
目的:用巢式聚合酶链反应(PCR)扩增全血中梅毒螺旋体(TP)的47KDa、15KDa的膜免疫原基因,以排除梅毒血清学试验假阳性。方法:用巢式PCR和常规PCR扩增90例疑似梅毒患者全血中的TpN15、TpN47,并与血清学方法比较。结果:与血清学方法比较,巢式PCR检测TP的敏感性和特异性分别为93。3%和96.7%,两者符合率为96.7%;两种PCR方法检测结果差异有显著性(P<0.01),巢
目的:探讨多体素质子磁共振波谱(1H-MRS)在阻塞性睡眠呼吸暂停低通气综合征(OSAHS)悬雍垂腭咽成形术(UPPP)前后的临床应用价值。材料与方法:20例中重度OSAHS患者行UPPP,术前及术后均行头颅多体素1H-MRS检查。分别记录半卵圆中心区、基底节区各代谢物比值,比较两者间的差异,并观察有无乳酸(Lac)峰出现。结果:术后半卵圆中心区NAA/Cr、NAA/Cho(分别为2.422±0.
Purpose Cystatin C has proposed as a surrogate of serum creatinine (Scr). The elderly population accounts for the largest proportion of the chronic kidney disease (CKD) patients. The aim of this study
会议